ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global RSV Vaccine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-18V15233
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global RSV Vaccine Market Research Report 2023
BUY CHAPTERS

Global RSV Vaccine Market Research Report 2025

Code: QYRE-Auto-18V15233
Report
May 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
GSK
Moderna, Inc
JNJ
Bavarian Nordic
Advaccine
Nuance Pharma

RSV Vaccine Market Size

The global market for RSV Vaccine was valued at US$ 182 million in the year 2024 and is projected to reach a revised size of US$ 296 million by 2031, growing at a CAGR of 7.3% during the forecast period.

RSV Vaccine Market

RSV Vaccine Market

Respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine which prevents infection by respiratory syncytial virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for RSV Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RSV Vaccine.
The RSV Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RSV Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RSV Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of RSV Vaccine Market Report

Report Metric Details
Report Name RSV Vaccine Market
Accounted market size in year US$ 182 million
Forecasted market size in 2031 US$ 296 million
CAGR 7.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Clinical I
  • Clinical II
  • Clinical III
  • Preclinical
  • Being Developed
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, GSK, Moderna, JNJ, Bavarian Nordic, Nuance Pharma, Advaccine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of RSV Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of RSV Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is RSV Vaccine Market growing?

Ans: The RSV Vaccine Market witnessing a CAGR of 7.3% during the forecast period 2025-2031.

What is the RSV Vaccine Market size in 2031?

Ans: The RSV Vaccine Market size in 2031 will be US$ 296 million.

Who are the main players in the RSV Vaccine Market report?

Ans: The main players in the RSV Vaccine Market are Pfizer, GSK, Moderna, JNJ, Bavarian Nordic, Nuance Pharma, Advaccine

What are the Application segmentation covered in the RSV Vaccine Market report?

Ans: The Applications covered in the RSV Vaccine Market report are Elderly Vaccine, Infant Vaccine, Others

What are the Type segmentation covered in the RSV Vaccine Market report?

Ans: The Types covered in the RSV Vaccine Market report are Clinical I, Clinical II, Clinical III, Preclinical, Being Developed

Recommended Reports

Respiratory Vaccines

Pediatric Vaccines

Adult & Elderly Vaccines

1 RSV Vaccine Market Overview
1.1 Product Definition
1.2 RSV Vaccine by Type
1.2.1 Global RSV Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Clinical I
1.2.3 Clinical II
1.2.4 Clinical III
1.2.5 Preclinical
1.2.6 Being Developed
1.3 RSV Vaccine by Application
1.3.1 Global RSV Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Elderly Vaccine
1.3.3 Infant Vaccine
1.3.4 Others
1.4 Global RSV Vaccine Market Size Estimates and Forecasts
1.4.1 Global RSV Vaccine Revenue 2020-2031
1.4.2 Global RSV Vaccine Sales 2020-2031
1.4.3 Global RSV Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 RSV Vaccine Market Competition by Manufacturers
2.1 Global RSV Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global RSV Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global RSV Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of RSV Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of RSV Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of RSV Vaccine, Product Type & Application
2.7 Global Key Manufacturers of RSV Vaccine, Date of Enter into This Industry
2.8 Global RSV Vaccine Market Competitive Situation and Trends
2.8.1 Global RSV Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest RSV Vaccine Players Market Share by Revenue
2.8.3 Global RSV Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global RSV Vaccine Market Scenario by Region
3.1 Global RSV Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global RSV Vaccine Sales by Region: 2020-2031
3.2.1 Global RSV Vaccine Sales by Region: 2020-2025
3.2.2 Global RSV Vaccine Sales by Region: 2026-2031
3.3 Global RSV Vaccine Revenue by Region: 2020-2031
3.3.1 Global RSV Vaccine Revenue by Region: 2020-2025
3.3.2 Global RSV Vaccine Revenue by Region: 2026-2031
3.4 North America RSV Vaccine Market Facts & Figures by Country
3.4.1 North America RSV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America RSV Vaccine Sales by Country (2020-2031)
3.4.3 North America RSV Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe RSV Vaccine Market Facts & Figures by Country
3.5.1 Europe RSV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe RSV Vaccine Sales by Country (2020-2031)
3.5.3 Europe RSV Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific RSV Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific RSV Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific RSV Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific RSV Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America RSV Vaccine Market Facts & Figures by Country
3.7.1 Latin America RSV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America RSV Vaccine Sales by Country (2020-2031)
3.7.3 Latin America RSV Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa RSV Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa RSV Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa RSV Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa RSV Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global RSV Vaccine Sales by Type (2020-2031)
4.1.1 Global RSV Vaccine Sales by Type (2020-2025)
4.1.2 Global RSV Vaccine Sales by Type (2026-2031)
4.1.3 Global RSV Vaccine Sales Market Share by Type (2020-2031)
4.2 Global RSV Vaccine Revenue by Type (2020-2031)
4.2.1 Global RSV Vaccine Revenue by Type (2020-2025)
4.2.2 Global RSV Vaccine Revenue by Type (2026-2031)
4.2.3 Global RSV Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global RSV Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global RSV Vaccine Sales by Application (2020-2031)
5.1.1 Global RSV Vaccine Sales by Application (2020-2025)
5.1.2 Global RSV Vaccine Sales by Application (2026-2031)
5.1.3 Global RSV Vaccine Sales Market Share by Application (2020-2031)
5.2 Global RSV Vaccine Revenue by Application (2020-2031)
5.2.1 Global RSV Vaccine Revenue by Application (2020-2025)
5.2.2 Global RSV Vaccine Revenue by Application (2026-2031)
5.2.3 Global RSV Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global RSV Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer RSV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer RSV Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK RSV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK RSV Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Moderna
6.3.1 Moderna Company Information
6.3.2 Moderna Description and Business Overview
6.3.3 Moderna RSV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Moderna RSV Vaccine Product Portfolio
6.3.5 Moderna Recent Developments/Updates
6.4 JNJ
6.4.1 JNJ Company Information
6.4.2 JNJ Description and Business Overview
6.4.3 JNJ RSV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 JNJ RSV Vaccine Product Portfolio
6.4.5 JNJ Recent Developments/Updates
6.5 Bavarian Nordic
6.5.1 Bavarian Nordic Company Information
6.5.2 Bavarian Nordic Description and Business Overview
6.5.3 Bavarian Nordic RSV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bavarian Nordic RSV Vaccine Product Portfolio
6.5.5 Bavarian Nordic Recent Developments/Updates
6.6 Nuance Pharma
6.6.1 Nuance Pharma Company Information
6.6.2 Nuance Pharma Description and Business Overview
6.6.3 Nuance Pharma RSV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nuance Pharma RSV Vaccine Product Portfolio
6.6.5 Nuance Pharma Recent Developments/Updates
6.7 Advaccine
6.7.1 Advaccine Company Information
6.7.2 Advaccine Description and Business Overview
6.7.3 Advaccine RSV Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Advaccine RSV Vaccine Product Portfolio
6.7.5 Advaccine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 RSV Vaccine Industry Chain Analysis
7.2 RSV Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 RSV Vaccine Production Mode & Process Analysis
7.4 RSV Vaccine Sales and Marketing
7.4.1 RSV Vaccine Sales Channels
7.4.2 RSV Vaccine Distributors
7.5 RSV Vaccine Customer Analysis
8 RSV Vaccine Market Dynamics
8.1 RSV Vaccine Industry Trends
8.2 RSV Vaccine Market Drivers
8.3 RSV Vaccine Market Challenges
8.4 RSV Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
GSK
Moderna, Inc
JNJ
Bavarian Nordic
Advaccine
Nuance Pharma
List of Tables
 Table 1. Global RSV Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global RSV Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global RSV Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global RSV Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global RSV Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global RSV Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global RSV Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market RSV Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of RSV Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of RSV Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of RSV Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of RSV Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global RSV Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RSV Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global RSV Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global RSV Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global RSV Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global RSV Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global RSV Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global RSV Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global RSV Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global RSV Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global RSV Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America RSV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America RSV Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America RSV Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America RSV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America RSV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe RSV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe RSV Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe RSV Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe RSV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe RSV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific RSV Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific RSV Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific RSV Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific RSV Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific RSV Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America RSV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America RSV Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America RSV Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America RSV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America RSV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa RSV Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa RSV Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa RSV Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa RSV Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa RSV Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global RSV Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global RSV Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global RSV Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global RSV Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global RSV Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global RSV Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global RSV Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global RSV Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global RSV Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global RSV Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global RSV Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global RSV Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global RSV Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global RSV Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global RSV Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global RSV Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global RSV Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global RSV Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global RSV Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global RSV Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer RSV Vaccine Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK RSV Vaccine Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Moderna Company Information
 Table 81. Moderna Description and Business Overview
 Table 82. Moderna RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Moderna RSV Vaccine Product
 Table 84. Moderna Recent Developments/Updates
 Table 85. JNJ Company Information
 Table 86. JNJ Description and Business Overview
 Table 87. JNJ RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. JNJ RSV Vaccine Product
 Table 89. JNJ Recent Developments/Updates
 Table 90. Bavarian Nordic Company Information
 Table 91. Bavarian Nordic Description and Business Overview
 Table 92. Bavarian Nordic RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bavarian Nordic RSV Vaccine Product
 Table 94. Bavarian Nordic Recent Developments/Updates
 Table 95. Nuance Pharma Company Information
 Table 96. Nuance Pharma Description and Business Overview
 Table 97. Nuance Pharma RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Nuance Pharma RSV Vaccine Product
 Table 99. Nuance Pharma Recent Developments/Updates
 Table 100. Advaccine Company Information
 Table 101. Advaccine Description and Business Overview
 Table 102. Advaccine RSV Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Advaccine RSV Vaccine Product
 Table 104. Advaccine Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. RSV Vaccine Distributors List
 Table 108. RSV Vaccine Customers List
 Table 109. RSV Vaccine Market Trends
 Table 110. RSV Vaccine Market Drivers
 Table 111. RSV Vaccine Market Challenges
 Table 112. RSV Vaccine Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of RSV Vaccine
 Figure 2. Global RSV Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global RSV Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Clinical I Product Picture
 Figure 5. Clinical II Product Picture
 Figure 6. Clinical III Product Picture
 Figure 7. Preclinical Product Picture
 Figure 8. Being Developed Product Picture
 Figure 9. Global RSV Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global RSV Vaccine Market Share by Application: 2024 & 2031
 Figure 11. Elderly Vaccine
 Figure 12. Infant Vaccine
 Figure 13. Others
 Figure 14. Global RSV Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global RSV Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 16. Global RSV Vaccine Sales (2020-2031) & (K Units)
 Figure 17. Global RSV Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 18. RSV Vaccine Report Years Considered
 Figure 19. RSV Vaccine Sales Share by Manufacturers in 2024
 Figure 20. Global RSV Vaccine Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest RSV Vaccine Players: Market Share by Revenue in RSV Vaccine in 2024
 Figure 22. RSV Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global RSV Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America RSV Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. North America RSV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. United States RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe RSV Vaccine Sales Market Share by Country (2020-2031)
 Figure 29. Europe RSV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 30. Germany RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific RSV Vaccine Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific RSV Vaccine Revenue Market Share by Region (2020-2031)
 Figure 37. China RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America RSV Vaccine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America RSV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa RSV Vaccine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa RSV Vaccine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE RSV Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of RSV Vaccine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of RSV Vaccine by Type (2020-2031)
 Figure 56. Global RSV Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of RSV Vaccine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of RSV Vaccine by Application (2020-2031)
 Figure 59. Global RSV Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 60. RSV Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Respiratory Syncytial Virus Vaccine for Children Market Research Report 2024
Global Respiratory Syncytial Virus Vaccine for the Elderly Market Research Report 2024
Global Respiratory Syncytial Virus Treatment Market Research Report 2024
Respiratory Syncytial Virus Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Syncytial Virus Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
RSV Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Syncytial Virus RSV Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pediatric Respiratory Syncytial Virus Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Respiratory Syncytial Virus Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Syncytial Virus RSV Infections Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Virus Vaccines Market Research Report 2024
Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Respiratory Syncytial Virus RSV Treatment Market Research Report 2024
Respiratory Syncytial Virus RSV Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Children Respiratory Syncytial Virus RSV Testing Market Research Report 2024
Measles Mumps and Rubella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Syncytial Virus RSV Antigen and Antibody Reagent Market Research Report 2024
Global Swine Reproductive and Respiratory Syndrome Vaccine Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions